Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 2;10(1):10859.
doi: 10.1038/s41598-020-67633-y.

Quantification of muco-obstructive lung disease variability in mice via laboratory X-ray velocimetry

Affiliations

Quantification of muco-obstructive lung disease variability in mice via laboratory X-ray velocimetry

Freda Werdiger et al. Sci Rep. .

Abstract

To effectively diagnose, monitor and treat respiratory disease clinicians should be able to accurately assess the spatial distribution of airflow across the fine structure of lung. This capability would enable any decline or improvement in health to be located and measured, allowing improved treatment options to be designed. Current lung function assessment methods have many limitations, including the inability to accurately localise the origin of global changes within the lung. However, X-ray velocimetry (XV) has recently been demonstrated to be a sophisticated and non-invasive lung function measurement tool that is able to display the full dynamics of airflow throughout the lung over the natural breathing cycle. In this study we present two developments in XV analysis. Firstly, we show the ability of laboratory-based XV to detect the patchy nature of cystic fibrosis (CF)-like disease in β-ENaC mice. Secondly, we present a technique for numerical quantification of CF-like disease in mice that can delineate between two major modes of disease symptoms. We propose this analytical model as a simple, easy-to-interpret approach, and one capable of being readily applied to large quantities of data generated in XV imaging. Together these advances show the power of XV for assessing local airflow changes. We propose that XV should be considered as a novel lung function measurement tool for lung therapeutics development in small animal models, for CF and for other muco-obstructive diseases.

PubMed Disclaimer

Conflict of interest statement

AF, CS, RC, RM, SD, DP, and MD have beneficial interests in 4Dx Limited, a company commercialising respiratory diagnostics technology. AF, SD, and CS are listed on patents filed by Monash University and 4Dx Limited describing the lung imaging technology.

Figures

Figure 1
Figure 1
Regional fractional expansion of the lung since the beginning of the breath is characterized as a fraction of the XV voxel. Coronal slices of the expansion at peak inspiration are shown for (a) a β-ENaC mouse (M3) and (b) a healthy littermate (M9). The red arrow indicates a large region with reduced expansion in the lungs of the β-ENaC mouse. This image, and all images like it in this paper, are generated by superimposing 3D fractional expansion data onto a 3D rendered volume of the lungs, before taking a coronal slice of the now pseudo-coloured volume (Avizo, ThermoFisher Scientific).
Figure 2
Figure 2
Comparative lung expansion analysis for a β-ENaC (M3, red) and littermate (M9, blue) pair of mice. (a) A histogram analysis of the fractional tissue displacement for the littermate and β-ENaC mice from Fig. 1, with the interquartile ranges of the normalised histogram shown as IQR. Note that Fig. 1 shows a single coronal slice, whereas the histogram is calculated from the entire volume. The fractional expansion for the β-ENaC mouse has a split peak. (b) The volume/time curve over the course of the ~ 0.5 s breath for the entire lung provides a global measurement of lung health. The volume of air breathed throughout the breath is expressed as a fraction of the entire lung volume; fractional volume. The healthy mouse breathes more air relative to the size of its lung. From this we can calculate the global expiratory time constant (τ).
Figure 3
Figure 3
(ac) show histograms from healthy littermates and (di) are those from β-ENaC mice. On each graph; the grey lines form the point along the histogram of the fraction expansion data and the broken black line represents the least squares double-Gaussian fit for the data. The goodness-of-fit is shown as R2. The extent of heterogeneous and clustered diseased is represented by HD and CD respectively, where a low CD and an HD value close to 1 indicates a healthy profile. In (h), the separate mode is indicated by the red arrow in addition to the bulge on the side of the main mode (blue arrow). The double gaussian fit summarises both deviations into a single curve.
Figure 4
Figure 4
Coronal slices through the 3D expansion volumes that correspond to the histograms shown in Fig. 3, with the same mice shown in corresponding panels. Panels (ac) show expansion maps from healthy littermates and (di) are those from β-ENaC mice. Note that a slice can reveal only a fraction of the whole volume, so does not necessarily reflect the level of disease heterogeneity that is apparent in Fig. 3.
Figure 5
Figure 5
Plot of HD and CD against FOT results for tissue hysteresivity. We expect larger values for all quantities in animals with more severe disease, but we have shown the CF-like disease presents in a more complex manner than can be captured by a single quantity; while littermates are clustered closely together, β-ENaC points clearly display large variability in the lung disease present in these mice. (a) We have separated the images/samples we assessed to be suffering from heart blur (black) from the rest of the samples; (b) CD is not calculated for heart-blur samples.
Figure 6
Figure 6
Heart blur throughout four different samples—all littermates—indicated by the red arrows. These areas record zero tissue displacement, as indicated by the colorbar at the left of the images.
Figure 7
Figure 7
A single CT slice from the first frame of sample M11. The arrows indicate the distinction between a blurred edge (red) between the heart and lung, as a result of heart motion, and a well-defined edge (yellow), more distant from the heart.
Figure 8
Figure 8
Mirror symmetry algorithm for automatic orientation and cropping. (a) A single slice from a CT reconstruction, pre-cropping. In (b), slices of the CT have been projected in the cranial/caudal direction to create a single image and the image thresholded to show the bones, revealing the symmetry of the ribcage. The red line indicates the line-of-best-symmetry as found by the algorithm, passing through the spine and sternum, allowing us to register their positions. (c) Using this result, the algorithm automatically corrects the orientation of the sample, and crops the image to the bones that act as a boundary for lung tissue; (d) shows a rotated and cropped slice.
Figure 9
Figure 9
A diagram of the image acquisition process. (a) Experimental schematic: The mouse is mounted on a rotation stage in front of the x-ray beam, generated by an electron beam hitting the liquid–metal jet anode, pumped under high pressure to retain a laminar flow. A small-animal ventilator ensures that the detector acquires images at a rate that is synchronized to the breathing pattern of the mouse. The vacuum tube (not shown) lies between the mouse and the detector; (b) An example of a single projection image collected by the detector as the animal is rotated in front of it; (c) A single slice from the CT reconstruction of the projections from a single time point (Adapted from).

References

    1. O’Neill K, et al. Lung clearance index in adults and children with Cystic Fibrosis. Chest. 2016;150:1323–1332. doi: 10.1016/j.chest.2016.06.029. - DOI - PubMed
    1. Mulligan M, Collins L, Dunne CP, Keane L, Linnane B. Determination of the lung clearance index (LCI) in a paediatric Cystic Fibrosis cohort. Ir. Med. J. 2017;110:629. - PubMed
    1. Shirai T, Kurosawa H. Clinical application of the forced oscillation technique. Intern. Med. 2016;55:559–566. doi: 10.2169/internalmedicine.55.5876. - DOI - PubMed
    1. Donnelley M, Parsons DW. Gene therapy for Cystic Fibrosis lung disease: Overcoming the barriers to translation to the clinic. Front. Pharmacol. 2018;9:3389. doi: 10.3389/fphar.2018.01381. - DOI - PMC - PubMed
    1. Tiddens HAWM, Kuo W, van Straten M, Ciet P. Pediatric lung imaging: the times they are a-changin’. Eur. Respir. Rev. 2018;27:170097. doi: 10.1183/16000617.0097-2017. - DOI - PMC - PubMed

Publication types